STREAMEX CORP. Other Non-Current Assets
STREAMEX CORP. (STEX) had Other Non-Current Assets of $15.46 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Noncurrent $15.46M.
- 2026-03-31: Other Assets, Noncurrent $15.22M.
- 2025-09-30: Other Assets, Noncurrent $44.00K.
- 2025-06-30: Other Assets, Noncurrent $44.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $15.46M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $15.22M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $44.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $44.00K 10-Q · filed 2025-08-15 |
| 2025-03-31 | $44.00K 10-Q · filed 2025-05-19 |
| 2024-12-31 | $44.00K 10-Q · filed 2025-11-14 |
| 2024-09-30 | $44.00K 10-Q · filed 2024-11-14 |
| 2023-12-31 | $44.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $687.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $514.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $244.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $44.00K 10-K · filed 2024-04-16 |
| 2022-09-30 | $44.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $43.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $424.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $438.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $444.74K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $453.49K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |